Support Genesis Foundation – An NGO for Heart Treatment in India Saving Little Hearts

Image
Genesis Foundation is a compassionate and dedicated NGO for heart treatment in India , focusing on helping children from underprivileged families who suffer from critical heart disorders. With millions of children born with congenital heart defects every year, the need for accessible treatment is urgent. Genesis Foundation bridges the gap by funding surgeries and interventions that save young lives. As a committed NGO for child heart surgery, we strive to remove the financial barriers that prevent children from getting the care they desperately need. Join us in giving them a future filled with health, happiness, and the joy of growing up.

Does Covid-19 affect children with heart disease?

In December 2019, the SARS-CoV-2 infection (COVID-19) was initially discovered in China as a new emerging disease. Subsequently, it has spread rapidly among other countries including Iran, and eventually, it was declared by the World Health Organization as a “pandemic” on 11th March 2020. The Health Ministry said that the common symptoms among children might include fever, cough, breathlessness or shortness of breath, fatigue, sore throat, myalgia (muscle pains, aches, pain in ligaments), rhinorrhea (excess drainage, ranging from a clear fluid to thick mucus from the nose), diarrhoea, loss of smell, loss of taste. Meanwhile, few children might also show symptoms of gastrointestinal issues.


But having said that, it is also reported that the prevalence of symptoms is lower in children compared to adults. Coronary artery diseases, heart failure, and cardiac arrhythmia have been associated with increased mortality among adults with COVID-19.



There is still a lack of knowledge and studies regarding children and adolescents suffering from congenital heart diseases (CHD) and COVID-19. SARS-CoV-2 infection may have direct cardiac involvement or indirect effects on the heart through respiratory and other organ involvements. As a Foundation working for children, Genesis Foundation has also struggled finding information. Theoretically, the effects of this infection on a pressure- or volume-overload heart in the setting of CHD may be more serious. In addition, risk factors for the severity of COVID-19 in patients with CHD are unknown. Genetic syndromes are usually seen in patients with CHD, but their effects in this situation are unknown. Discovering the impacts of CHD on the course and outcome of COVID-19 enables physicians to set priorities for emergency interventions. 

Although children with COVID-19 are often asymptomatic, special underlying congenital heart defects can predispose to serious and rarely fatal outcomes. Of particular importance is the burden of disease in patients with severe untreated obstructive lesions (Right ventricular outflow tract obstruction (RVOT) or left ventricular outflow tract obstruction (LVOT) and patients with significant Pulmonary artery hypertension (PAH). The RVOT is generally associated with Tetralogy of Fallot, Pulmonary Atresia. 

The clinical symptoms, CT scan findings, and laboratory parameters of COVID-19 are similar among children with normal heart or those having Congenital Herat Defects. Heart failure can be seen due to myocarditis or as a manifestation of Multisystem Inflammatory Syndrome in children presented with mild transient ventricular dysfunction without any rise in cardiac enzymes. 

As a children’s heart Foundation, we are closely watching the long-term effects of children with CHD and COVID, which is still an area of ongoing research. Genesis Foundation (www.genesis-foundation.net) is a Foundation working for children with Congenital Heart Defects. As a Children Heart Foundation, some of the children supported by the Foundation were infected with COVID before undergoing treatment for Congenital Heart Defects. But surgery was postponed until their Covid results turned negative, and currently they all are doing well.


References: 

M. R. Mehra, S. S. Desai, S. Kuy, T. D. Henry, and A. M. Patel, “Cardiovascular disease, drug therapy, and mortality in COVID-19,” New England Journal of Medicine.


Comments

Popular posts from this blog

Little Nafisa overcomes Pulmonary Stenosis through CSR support for healthcare

The simple steps to fund medical treatments with the help of donations in India